FORA Capital, LLC

Position in AXSM — Axsome Therapeutics, Inc.

CIK 1742435 MIAMI, FL

Position in AXSM

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,557,716

+$1,312,637 QoQ

Shares Held

6,364

+338.9% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#241

of 500 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FORA Capital, LLC holds $19,737,715 across 20 Biotechnology names. AXSM ranks #4 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	5,209	$1,568,065
2	ABVX	Abivax S.A.	11,758	$1,566,871
3	ROIV	Roivant Sciences Ltd.	44,129	$1,561,725
4	AXSM	Axsome Therapeutics, Inc. This page	6,364	$1,557,716
5	TVTX	Travere Therapeutics, Inc.	27,289	$1,550,288
6	PRAX	Praxis Precision Medicines, Inc.	4,205	$1,407,791
7	REGN	Regeneron Pharmaceuticals, Inc.	2,147	$1,338,740
8	JAZZ	Jazz Pharmaceuticals plc	5,408	$1,303,165

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,557,716	6,364	+338.9%	Shares	Sole	2026-08-13
2026-03-31	$245,079	1,450	-74.6%	Shares	Sole	2026-05-15
2025-12-31	$1,043,604	5,714	-25.1%	Shares	Sole	2026-02-13
2025-03-31	$890,236	7,633	-31.0%	Shares	Sole	2025-05-14
2024-09-30	$993,782	11,058	+24.1%	Shares	Sole	2024-11-13
2023-12-31	$708,908	8,907	+97.7%	Shares	Sole	2024-02-14
2022-09-30	$201,013	4,505	-72.2%	Shares	Sole	2022-11-14
2022-06-30	$621,149	16,218	+85.5%	Shares	Sole	2022-08-11
2022-03-31	$361,831	8,742	+1012.2%	Shares	Sole	2022-05-12
2021-06-30	$53,023	786	-85.0%	Shares	Sole	2021-08-16
2020-12-31	$426,658	5,237	+1578.5%	Shares	Sole	2021-02-12
2020-09-30	$22,230	312	-95.2%	Shares	Sole	2020-11-13
2020-06-30	$535,231	6,505	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.